Versant Ventures Closes $500M Fund
Menlo Park-based Versant Ventures said Thursday that it has closed a $500M venture capital fund focused on the biotechnology, pharmaceuticals, and medical devices area. The early stage venture capital firm said that the close of Versant Venture Capital IV, L.P., brings the company's total under management to more than $1.6 billion. The new fund will target 30-35 medical device, biotech, and pharmaceutical investments throughout the U.S. Versant Venturs also has offices in Newport Beach, California.
posted on Thursday, July 31, 2008
Related companies:
Versant Health, Inc.
Related stories:
> Clarus Ventures Raises $500M Fund
> Vivo Ventures Closes $375M Healthcare Fund
> Vivo Ventures Closes $275M Life Science Venture Fund
> Symantec Closes $500M Investment From Silver Lake
> Sorenson Ventures Closes $110M Fund
silicontap.com Home